
Theranostics for personalized cancer care
Partnering together for the future of precision oncology
Did this information help you?
1
Cancer Research UK. Worldwide cancer incidence statistics. Available at https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence.
2
syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices on their own right. syngo.via and the syngo.via based software options are not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
3
Syngo Carbon consists of several products which are (medical) devices in their own right. Some products are under development and not commercially available. Future availability cannot be ensured.
4
Up to 588keV.
5
Subject to scanner bed weight limit.
The products and features (mentioned herein) are not commercially available in all countries. Future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer鈥檚 unique setting. Since there is no 鈥渢ypical鈥 hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption), there can be no guarantee that other customers will achieve the same results.